China Renaissance Capital Investment is a private equity and venture capital firm specializing in early, middle market, late venture, Growth Capital and Buyout investments. For early stage investments, the firm seeks to invest in high technology innovation in pharmaceuticals. It seeks to invest in the technology, media, fintech, smart manufacturing, automation, robots, hardware technology, infrastructure, telecom, retail, healthcare, and education sectors. The firm seeks to invest in companies based in Greater China, Taiwan, Macau, and Hong Kong. It prefers to invest between $20 million and $75 million. The firm also prefers to invest in companies having annual revenue between $100 million and $200 million. It prefers to take majority stake in its portfolio companies. China Renaissance Capital Investment was founded in June 2005 and is based in Central, Hong Kong, with additional offices in Chengdu, China; Shanghai, China; and Beijing, China.

UNC Kenan-Flagler Private Equity Fund is a student-run private equity and venture capital firm located in Chapel Hill, North Carolina, established in 2007. The fund focuses on making investments in both early and late-stage companies, engaging in buyouts, growth capital, and mezzanine debt financings. It aims to invest between $0.1 million and $0.15 million in portfolio companies that typically have enterprise values ranging from $20 million to $125 million. The fund operates with the dual purpose of delivering real returns for investors while providing an educational experience for its student members. It collaborates with partner private investment firms to enhance its investment strategies and reach.

Country Garden Venture Capital, established in January 2019, operates as a first-level business unit of Country Garden Group and is headquartered in Shenzhen, China. The firm focuses on equity investments and real estate, adhering to an investment strategy centered around "industry empowerment and value co-creation." It balances financial and holding investments, developing a diverse portfolio across various stages and sectors. Country Garden Venture Capital targets multiple industries, including advanced manufacturing, consumption, healthcare, infrastructure, and supply chain. The firm has invested in notable companies such as Shell Search, Qinhuai Data, Ziguang Zhanrui, Penguin Almond, Hobo Pharmaceutical, Blue Arrow Aerospace, and Xinruipeng Pet Medical, among others.

Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage investments in technology and healthcare, with interests spanning information technology, life sciences and related sectors in the United States. The firm has supported a broad portfolio of companies, including Apple, Intel, Illumina, DoubleClick, Athenahealth, Gilead Sciences, Nest, SlideShare and Tudou. Venrock emphasizes long-term partnerships with entrepreneurs, combining hands-on venture support with rigorous data analysis to help startups grow into enduring companies.

Founded in 1999, Versant Ventures is a global healthcare investment firm dedicated to supporting exceptional entrepreneurs building innovative companies. With over $2 billion under management and offices across North America and Europe, the firm invests across all stages of healthcare company development, with a focus on novel therapeutics. Versant's team, with deep investment, operating, and scientific expertise, takes a hands-on approach to company building.

Founded in 2016, Pivotal BioVenture Partners is a venture capital firm based in San Francisco. It invests in early-stage biotechnology companies focused on innovative therapeutic products and platforms across North America and Europe.

Samsara BioCapital is a venture capital firm based in Palo Alto, California, that focuses on biotechnology and life sciences companies in the United States. The firm seeks to invest in pharmaceutical and biotechnology ventures, including oncology and other healthcare technologies, with a goal of supporting entrepreneurs in turning ideas into developed therapies. It emphasizes collaboration with ambitious partners and aims to advance biotech innovation and important new therapies by providing capital and advisory support. The organization also operates as a registered investment adviser, offering investment advisory services to guide portfolio companies through growth and development.

Incubate Fund is an independent venture capital firm founded in 2010 and based in Tokyo, Japan. It specializes in seed and early-stage investments in technology startups, backing entrepreneurship across Asia. The firm has built a portfolio of more than 300 companies and has delivered multiple exits, including 12 initial public offerings and 20 mergers and acquisitions since its inception. It maintains a broad sector focus that spans business products and services, consumer products and services, information technology and the Internet of Things, as well as media, entertainment, games, commerce, logistics, medical, financial services, real estate, automobiles, and housing-related innovation. Through its regional presence in Asia, the firm supports founders from early development through scaling, aiming to back ambitious teams with potential for significant growth.

Established in November 2013, Cool Japan Fund is a public-private initiative aimed at fostering international demand for exceptional Japanese products and services. It achieves this by providing risk capital to businesses across various sectors such as media & content, food & services, fashion & lifestyle.

Canal Ventures is a corporate venture capital firm founded in 2017 and based in Tokyo, Japan. It operates as the venture capital arm of the Nihon Unisys Group and focuses on investing in seed and early-phase startups. The firm primarily targets the technology sector, emphasizing investments that address social causes. Through its investments, Canal Ventures aims to support innovative solutions that contribute positively to society while fostering growth in emerging companies.

Boost VC is an early-stage venture capital firm based in San Mateo, California. Founded in 2012 by Adam Draper and Brayton Williams, the firm focuses on deep tech startups across the United States, including aerospace, robotics, hardware and software, bio/health, energy and climate, crypto, defense, space, artificial intelligence, and immersive technologies such as augmented and virtual reality. It typically participates in pre-seed and very early rounds, often leading initial investments in technology companies at the earliest stages of development, and it manages around $200 million in assets.

Empower Investment is a venture capital firm founded in 2012 and headquartered in Shanghai, China. The firm specializes in early-stage ventures, mid-stage growth, and public market securities. With branch offices in Beijing, Shenzhen, Hangzhou, and Chengdu, Empower Investment has a global reach, having invested in over 150 high-tech and high-growth companies across regions including China, the U.S., India, South Korea, Vietnam, and Hong Kong. Its portfolio spans various fast-growing sectors such as internet technology, artificial intelligence, big data, automation and robotics, financial technology, cultural creativity, advanced materials, and healthcare. The Empower team possesses extensive expertise in deep technologies and financial services, with members having backgrounds in internet, computer science, electronic engineering, materials science, auditing, and investment banking. Some team members are also serial entrepreneurs. Empower Investment is committed to partnering with visionary and determined entrepreneurs to foster innovation and build a brighter future.

Ufida Happiness Capital is a Beijing-based venture capital and private equity firm that invests in software and information technology companies. Founded in 2010, it focuses on backing firms in the software and IT sectors and seeks to support modernization of IT service delivery through its portfolio.

Vectr Ventures is a Hong Kong-based early-stage venture capital firm founded in 2014. It offers capital and strategic support to startups seeking to transform industries and tackle global issues, with a focus on helping teams scale and expand into Asia.

Oriza Holdings is an asset management firm based in Suzhou, China, founded in 2001. The company specializes in providing equity and debt financing solutions to companies at various stages of development, from seed to growth stages. Oriza Holdings operates through multiple investment arms, focusing on sectors such as industrial, healthcare, integrated circuits, and technology, media, and telecommunications (TMT). The company also has a professional platform for mergers and acquisitions, known as Oriza Prior, which integrates investment and industrial resources to enhance operational efficiency and maximize investment returns. With a commitment to fostering growth, Oriza Holdings plays a significant role in the Southeast Asian market.

Founded in 2007, SBI Ven Capital is a venture capital firm based in Singapore. It invests primarily in financial services and technology sectors across Asia.

Sequoia Capital Israel is a venture capital firm that backs startups and growth companies across seed to late-stage rounds, with a focus on Israel. It invests across sectors including fintech, financial services, internet, mobile, technology, and healthcare, spanning banking, payments, advertising, ecommerce, data, security, software, and related enabling tech. Typical commitments range from 100,000 to 1 million in seed, 1 to 10 million in early venture, and 10 to 100 million in growth rounds. The firm is based in Tel Aviv and operates as part of Sequoia Capital's global network.

Domain Associates is a New Jersey-based venture capital firm focused on life sciences and healthcare. Founded in 1985 and headquartered in Princeton with a second office in San Diego, the firm concentrates its investments in pharmaceuticals, specialty pharmaceuticals, and medical devices, with additional interest in biomaterials, bioinstrumentation, and diagnostics. The team brings extensive healthcare experience and has been involved in forming and growing a large number of life-sciences companies, leveraging its targeted network to support early through growth-stage ventures.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, with offices in San Francisco. Founded in 1996, it targets investments in technology and life science companies across the United States and Europe, supporting startups from early formation to profitable growth. The firm's healthcare and biotechnology focus encompasses digital health, consumer-centric care delivery, patient-provider solutions, data science and analytics, as well as therapeutics, genomics and other life science platforms. It backs companies across business-to-business and business-to-consumer models, software as a service, healthcare information technology and health tech sectors, partnering with repeat entrepreneurs to build durable, scale-ready businesses.

GGV Capital is a global venture capital firm that invests in technology companies across various stages and sectors. Established in 2000, the firm has offices in Silicon Valley, Singapore, and Beijing, providing expansion capital ranging from $5 to $25 million for initial investments. GGV Capital focuses on companies operating in the U.S., China, India, Southeast Asia, Japan, Australia, Europe, and Israel.

Notable Capital is named for the founders we invest with, the ideas they pursue, the causes they champion, and the remarkable companies they build. Notable is a U.S.-based venture capital firm focused on early-to-growth stage companies in cloud infrastructure and business and consumer applications across the U.S., Israel, Europe, Latin America, and select go-global opportunities. Notable portfolio companies include Affirm, Airbnb, Block, Brightwheel, Drata, Handshake, HashiCorp, Ibotta, Orca Security, Quince, Slack, Slice, StockX, Stori, Vercel, Zendesk, and more.

SAIF Partners is a Hong Kong-based private equity firm founded in 2001 that provides growth capital and minority investments to companies across Asia, with a focus on China and India. The firm pursues privately negotiated equity and equity-linked investments across sectors including information technology, Internet, mobile, consumer products and services, healthcare, financial services, education, cleantech, manufacturing, and other TMT areas. It maintains local teams in Hong Kong, China, and India and has a large investment portfolio, managing over $4 billion in capital as a long-term investor.

Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. It invests globally in technology and healthcare sectors, supporting entrepreneurs with its extensive domain expertise and relationships.